VerifiedBiotechnology Research· Founded 2018

Bold Therapeutics Inc

Bold Therapeutics is the world leader in the development of novel metallotherapeutics. Bold Therapeutics' lead program, BOLD-100, has demonstrated positive safety and efficacy in Phase 2 clinical trials in colorectal, biliary tract and gastric cancers, with presentations at ASCO 2024 and ASCO GI 2024. Bold Therapeutics expects to initiate pivotal Phase 3 trials in the near future.

7-day free trial · no credit card

Vancouver, Canada17(11 to 50)$1M to <$10M2018bold-therapeutics.com LinkedIn

Verified contacts

11

available on Kipplo

LinkedIn employees

17

11 to 50 range

Open roles

—

no listings

Distinct roles

10

indexed titles

Tech stack

0

tools in use

Monthly traffic

219

organic / mo

Sign up free to see all 11 verified contacts at Bold Therapeutics Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

11 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 8 of 11 verified contacts

Top roles at Bold Therapeutics Inc

10 distinct titles indexed · top 10 shown.

1clinical development associate
1evp, clinical development
1manager, cmc
1member board of directors
1operations associate
1postdoctoral fellow
1president and ceo
1senior data scientist
1senior director of preclinical development
1senior scientist

Sign up to unlock all 11 contacts at Bold Therapeutics Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 11 verified contacts at Bold Therapeutics Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Bold Therapeutics Inc | Kipplo Discover